Scinovex
review Open AccessTop 1% cited

Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?

Hypertension · 2003 · Vol. 41(6) · pp. 1183–1190
Richard J. JohnsonDuk‐Hee KangDaniel I. FeigSalah D. KivlighnJohn KanellisSusumu WatanabeKatherine R. TuttleBernardo Rodríguez‐IturbeJaime Herrera-AcostaMarilda Mazzali

Abstract

Hyperuricemia is associated with hypertension, vascular disease, renal disease, and cardiovascular events. In this report, we review the epidemiologic evidence and potential mechanisms for this association. We also summarize experimental studies that demonstrate that uric acid is not inert but may have both beneficial functions (acting as an antioxidant) as well as detrimental actions (to stimulate vascular smooth muscle cell proliferation and induce endothelial dysfunction). A recently developed experimental model of mild hyperuricemia also provides the first provocative evidence that uric acid may have a pathogenic role in the development of hypertension, vascular disease, and renal disease. Thus, it is time to reevaluate the role of uric acid as a risk factor for cardiovascular disease and hypertension and to design human studies to address this controversy.

Gout, Hyperuricemia, Uric AcidAlcohol Consumption and Health EffectsCase Reports on HematomasHyperuricemiaUric acidMedicineDiseaseVascular diseaseEndothelial dysfunctionKidney diseaseInternal medicineRisk factorEndocrinology

MeSH terms

AnimalsAntioxidantsCardiotonic AgentsCardiovascular DiseasesFemaleHumansHypertensionKidney DiseasesMaleModels, CardiovascularRisk FactorsUric AcidHyperuricemia

Funding

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • National Institutes of Health
Citations
1,360
FWCI
23.68
field-weighted impact
References
108
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.